Ataluren
PTC124-GD-020e-DMD
Phase 3 small_molecule terminated
Quick answer
Ataluren for Muscular Dystrophy, Duchenne is a Phase 3 program (small_molecule) at PTC THERAPEUTICS, INC. with 3 ClinicalTrials.gov record(s).
Program details
- Company
- PTC THERAPEUTICS, INC.
- Indication
- Muscular Dystrophy, Duchenne
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated